BMS-561392 (compound 3 in Table 2, Figure 2) is an orally active, partially selective inhibitor of TACE. [19] It also targets MMP3 and MMP12 as well as ADAMTS4 (ADAM with thrombospondin motifs 4 ...
Some results have been hidden because they may be inaccessible to you